TrialsgrambetaRCTs are beautiful
ESC Congress 2026Presentado sáb, 29 ago · 16:45 CESTHot Line 4Todos los ensayos Hot Line →

AIR-STEMI

2026

Functional Coronary Angiography to Indicate and Guide Revascularization in STEMI Patients With Multivessel Disease (AIR-STEMI)

In 1,823 patients with STEMI and multivessel disease, angiography-derived FFR-guided non-culprit PCI reduced death, stroke, reinfarction or ischaemia-driven revascularisation compared with angiography-guided PCI.

Resultado

Eficacia: Patient-oriented composite of all-cause death, cerebrovascular accident, reinfarction or ischaemia-driven revascularisationHR 0,62 (IC del 95% 0,47-0,83) · P < 0,001

Seguridad: Contrast-associated kidney injuryHR 0,55

Por debajo de 1 a favor de angiography-derived FFR-guided non-culprit PCI, por encima de 1 a favor de angiography-guided PCI.

Tasas de eventos Angiography-derived FFR-guided non-culprit PCI 8,9% vs. angiography-guided PCI 13,7% (patient-oriented composite of all-cause death, cerebrovascular accident, reinfarction or ischaemia-driven revascularisation)

También se informa: Cardiovascular death or myocardial infarction HR 0.52 (0.37-0.73); myocardial infarction 3.8% vs 8.0% (HR 0.47), both spontaneous and procedure-related. The physiology arm used 38% fewer staged procedures, treated 45% fewer non-culprit vessels and implanted 31% less stent length.

Publicación original
Subtema
Physiology-guided revascularisation
Diseño
Prospective, international, multicentre, randomised, open-label trial with blinded adjudication of outcomes by an independent clinical events committee; 1:1 randomisation after successful culprit-lesion PCI; non-culprit PCI indicated and planned by angiography-derived FFR versus conventional angiography; follow-up censored when the last enrolled patient reaches 1 year (average about 18 months), with endpoints also assessed at 3 and 5 years
Relevancia
Importante: uno de varios pilares.
Fuente
Biscaglia S, Campo G, et al. N Engl J Med. 2026; published online 29 August.doi 10.1056/nejmoa2605373

Discusión y crítica

Reading physiology off the angiogram rather than crossing every lesion with a wire cut the composite by nearly two fifths, and the mechanism is visible in the procedure log: fewer staged procedures, fewer vessels treated, less stent, less contrast. Reinfarction fell for both spontaneous and procedure-related events, which argues that some of the benefit is simply harm not done. Two caveats: the trial is open-label with ischaemia-driven revascularisation in the primary endpoint, a component the operator can influence, and the FFR values came from a central core laboratory rather than the local cath lab.

Comentado en pódcasts